← All trials
NCT06488625
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 12, 2024
- Primary completion
- Oct 31, 2027
- Completion date
- Dec 31, 2027
- First posted
- Jul 5, 2024
- Last posted
- Nov 6, 2024
- Enrollment
- 459
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universitaetsklinikum Schleswig-HolsteinLead sponsor
- Ced Service GmbHCollaborator
- Gesellschaft für Therapieforschung mbHCollaborator
- German Federal Ministry of Education and ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.